Hassan Mozan, Abdelnabi Hiba Atiyah, Mohsin Sahar
Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Pharmaceutics. 2024 Feb 15;16(2):273. doi: 10.3390/pharmaceutics16020273.
Recently, nanotechnologies have become increasingly prominent in the field of bone tissue engineering (BTE), offering substantial potential to advance the field forward. These advancements manifest in two primary ways: the localized application of nanoengineered materials to enhance bone regeneration and their use as nanovehicles for delivering bioactive compounds. Despite significant progress in the development of bone substitutes over the past few decades, it is worth noting that the quest to identify the optimal biomaterial for bone regeneration remains a subject of intense debate. Ever since its initial discovery, poly(lactic-co-glycolic acid) (PLGA) has found widespread use in BTE due to its favorable biocompatibility and customizable biodegradability. This review provides an overview of contemporary advancements in the development of bone regeneration materials using PLGA polymers. The review covers some of the properties of PLGA, with a special focus on modifications of these properties towards bone regeneration. Furthermore, we delve into the techniques for synthesizing PLGA nanoparticles (NPs), the diverse forms in which these NPs can be fabricated, and the bioactive molecules that exhibit therapeutic potential for promoting bone regeneration. Additionally, we addressed some of the current concerns regarding the safety of PLGA NPs and PLGA-based products available on the market. Finally, we briefly discussed some of the current challenges and proposed some strategies to functionally enhance the fabrication of PLGA NPs towards BTE. We envisage that the utilization of PLGA NP holds significant potential as a potent tool in advancing therapies for intractable bone diseases.
近年来,纳米技术在骨组织工程(BTE)领域日益突出,为推动该领域发展提供了巨大潜力。这些进展主要体现在两个方面:纳米工程材料的局部应用以促进骨再生,以及将其用作递送生物活性化合物的纳米载体。尽管在过去几十年中骨替代物的开发取得了重大进展,但值得注意的是,寻找用于骨再生的最佳生物材料仍是一个激烈争论的话题。自最初发现以来,聚乳酸-乙醇酸共聚物(PLGA)因其良好的生物相容性和可定制的生物降解性而在骨组织工程中得到广泛应用。本综述概述了使用PLGA聚合物开发骨再生材料的当代进展。综述涵盖了PLGA的一些特性,特别关注这些特性针对骨再生的改性。此外,我们深入探讨了合成PLGA纳米颗粒(NPs)的技术、这些NPs可以制造的不同形式,以及对促进骨再生具有治疗潜力的生物活性分子。此外,我们还讨论了当前对市场上PLGA NPs和基于PLGA的产品安全性的一些担忧。最后,我们简要讨论了当前的一些挑战,并提出了一些策略来功能增强PLGA NPs用于骨组织工程的制造。我们设想,PLGA NPs的利用作为推进难治性骨疾病治疗的有力工具具有巨大潜力。